Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01878669 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention

Study acronym: EASE-PCI
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Dec 2024 to Dec 2026v19
  2. Study completion date: Dec 2023 to Dec 2024v18
  3. Study completion date: May 2023 to Dec 2023v17
  4. Study completion date: Nov 2022 to May 2023v16
  5. Study completion date: Nov 2021 to Nov 2022v15
Show 13 earlier versionsHide 13 earlier versions
  1. Study completion date: Jun 2021 to Nov 2021v14
  2. Study completion date: Aug 2020 to Jun 2021v13
  3. Study completion date: Feb 2020 to Aug 2020v12
  4. Study completion date: Jun 2019 to Feb 2020v11
  5. Study completion date: Jun 2018 to Jun 2019v10
  6. Primary completion date changed from estimate of Jun 2017 to Sep 2017
    • Study completion date: Dec 2017 to Jun 2018
    v9
  7. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: 460 to 390
    • Site details revised
    v8
  8. Re-verified, no change to tracked fieldsv7
  9. Primary completion date: Jan 2016 to Jun 2017
    • Enrollment target: 400 to 460
    • Study completion date: Jun 2016 to Dec 2017
    v6
  10. Primary completion date: Jan 2015 to Jan 2016
    • Study completion date: Jun 2015 to Jun 2016
    v5
  11. Study completion date: Jun 2015v4
  12. Eligibility criteria expanded, about 1 wordv3
  13. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to evaluate the effects of N-acetyl cysteine on periprocedural myocardial infarction and major cardiac and cerebral events in patients undergoing percutaneous coronary intervention and who have moderate to high risk for contrast induced nephropathy.
Trial Details
NCT Number NCT01878669
Lead Sponsor Suleyman Demirel University
Conditions
(from sponsor)		 Coronary Artery Disease
Related terms Coronary Artery Disease
Enrollment 390 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov